These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3127338)

  • 1. Reaction of myasthenic antibodies with heart & brain nicotinic acetylcholine receptors.
    Asthana D; Jaffery NF; Kumar R; Ahuja GK; Jailkhani BL
    Indian J Med Res; 1987 Oct; 86():493-9. PubMed ID: 3127338
    [No Abstract]   [Full Text] [Related]  

  • 2. Absence of acetylcholine receptor antibody in relatives of myasthenic patients.
    Walker GL; Nicholson LV; Mastaglia FL
    Lancet; 1980 Apr; 1(8171):778-9. PubMed ID: 6103204
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antibodies to acetylcholine receptor. Diagnosis and therapeutic interest in myasthenia gravis (author's transl)].
    de Crousaz G
    Ann Chir; 1980 Mar; 34(3):188-92. PubMed ID: 7369693
    [No Abstract]   [Full Text] [Related]  

  • 4. ELISA for detection of IgG & IgM antibodies to human nicotinic acetylcholine receptor in myasthenia gravis.
    Jailkhani BL; Asthana D; Jaffery NF; Khajuria A; Subbalaxmi B; Ahuja GK
    Indian J Med Res; 1986 Feb; 83():187-95. PubMed ID: 3710546
    [No Abstract]   [Full Text] [Related]  

  • 5. Antibodies to synthetic peptide (125-148) of the alpha-subunit of human nicotinic acetylcholine receptor in sera from patients with myasthenia gravis.
    Ohta M; Ohta K; Itoh N; Nishitani H; Hara H; Hayashi K
    Neurology; 1990 Nov; 40(11):1776-8. PubMed ID: 2234435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune diseases involving nicotinic receptors.
    Lindstrom J
    J Neurobiol; 2002 Dec; 53(4):656-65. PubMed ID: 12436428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myasthenia gravis studied by monoclonal antibodies to the acetylcholine receptor.
    Tzartos SJ
    In Vivo; 1988; 2(1):105-10. PubMed ID: 2979808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies against muscle and brain nicotinic acetylcholine receptors in IgA-deficient patients with epilepsy.
    Fontana A; Fulpius BW; Cuénoud S
    Adv Cytopharmacol; 1979; 3():287-92. PubMed ID: 474298
    [No Abstract]   [Full Text] [Related]  

  • 9. A simplified ELISA for anti-receptor antibodies in myasthenia gravis.
    Jailkhani BL; Asthana D; Jaffery NF; Kumar R; Ahuja GK
    J Immunol Methods; 1986 Jan; 86(1):115-8. PubMed ID: 3944465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up study of relapse in symptoms and reelevation of acetylcholine receptor antibody titers in patients with myasthenia gravis.
    Komiya T; Sato T
    Ann N Y Acad Sci; 1988; 540():605-7. PubMed ID: 3207287
    [No Abstract]   [Full Text] [Related]  

  • 11. alpha-Bungarotoxin displacing antibody in myasthenia gravis.
    Barkas T; Simpson JA
    J Clin Lab Immunol; 1982 Nov; 9(2):113-7. PubMed ID: 7154056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A modified assay for antibody against the nicotinic acetylcholine receptor in myasthenia gravis.
    Dwyer DS; Bradley RJ; Oh SJ; Kemp GE
    Clin Exp Immunol; 1979 Sep; 37(3):448-51. PubMed ID: 509779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigenic structure of the muscle nicotinic acetylcholine receptor.
    Tzartos SJ; Cung MT; Mamalaki A; Marraud M; Papanastasiou D; Sakarellos C; Sakarellos-Daitsiotis M; Tsantili P
    Ann Med Interne (Paris); 1996; 147(6):442-6. PubMed ID: 9092347
    [No Abstract]   [Full Text] [Related]  

  • 14. Mesangial proliferative glomerulonephritis with deposits of anti-nicotinic acetylcholine receptor antibody in a patient with myasthenia gravis.
    Mitsui T; Okada K; Kuhara T; Hashizume T; Okazaki S; Kawajiri M; Matsumoto T
    J Clin Neurosci; 2001 Sep; 8(5):454-6. PubMed ID: 11535018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myasthenia gravis and myasthenic syndrome.
    Antozzi C
    Neurol Sci; 2003 Oct; 24 Suppl 4():S260-3. PubMed ID: 14598056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myasthenia gravis: nicotinic acetylcholine receptors as targets for autoimmune attack.
    Newsom-Davis J; Harcourt G; Beeson D
    Biochem Soc Trans; 1989 Aug; 17(4):635-7. PubMed ID: 2670631
    [No Abstract]   [Full Text] [Related]  

  • 17. Skeletal and heart muscle antibodies in myasthenia gravis. A new immunofluorescence pattern.
    Cossio PM; Cornejo L; Herrera M; Vasquez C; Arana RM
    Biomedicine; 1973 Jun; 19(6):261-6. PubMed ID: 4584701
    [No Abstract]   [Full Text] [Related]  

  • 18. [Structure-function relationship of nicotinic acetylcholine receptor].
    Nomoto H; Hayashi K; Ohta M
    Tanpakushitsu Kakusan Koso; 1990 Mar; 35(4 Suppl):663-76. PubMed ID: 1692142
    [No Abstract]   [Full Text] [Related]  

  • 19. Thymus histology and acetylcholine receptor antibodies in generalized myasthenia gravis.
    Oger JJ
    Ann N Y Acad Sci; 1993 Jun; 681():110-2. PubMed ID: 8357159
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of acetylcholine receptor antibodies in myasthenia gravis.
    Appel SH; Elias SB; Chauvin P
    Fed Proc; 1979 Sep; 38(10):2381-5. PubMed ID: 478014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.